As of Jul 30
| +0.17 / +1.42%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a -9.17% decrease from the last price of 12.11.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.